Mechanism of Azalomycin F

Li Xu, Xuejie Xu, Ganjun Yuan, Yimin Wang, Yunqiu Qu, Erxiao Liu

Open access · hybridAbstract read

In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it

0cells of the map it votes in

6citing papers in PubMed

1.2field-weighted citation impact, top 24% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

Insights into azalomycin F assembly-line contribute to evolution-guided polyketide synthase engineering and identification of intermodular recognition.Nature communications · 2023
Article
Pharmacokinetics of Azalomycin F, a Natural Macrolide Produced by Streptomycete Strains, in Rats.Molecules (Basel, Switzerland) · 2021
Article
Lichen-like association of Chlamydomonas reinhardtii and Aspergillus nidulans protects algal cells from bacteria.The ISME journal · 2020
Article
Azalomycin FInternational journal of molecular sciences · 2020
Article
Newly IsolatedFrontiers in microbiology · 2020
Article
Guanidine-Containing Polyhydroxyl Macrolides: Chemistry, Biology, and Structure-Activity Relationship.Molecules (Basel, Switzerland) · 2019
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Li XuCollege of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang, Jiangxi 330045, China.

Xuejie XuCollege of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang, Jiangxi 330045, China.

Ganjun YuanCollege of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang, Jiangxi 330045, China.ORCID 0000-0002-4944-1144

Yimin WangCollege of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang, Jiangxi 330045, China.

Yunqiu QuAffiliated Hospital of Jiangxi Agricultural University, Nanchang, Jiangxi 330045, China.ORCID 0000-0002-1578-5731

Erxiao LiuCollege of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang, Jiangxi 330045, China.

Jiangxi Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the mechanism of azalomycin F

Indexed as

Adenylate KinaseBacterial ProteinsMacrolidesMembrane LipidsMethicillin-Resistant Staphylococcus aureusPhosphatidylglycerols1,2-dipalmitoylphosphatidylglycerolAdenylate Kinaseazalomycin F5aBacterial ProteinsMacrolidesMembrane LipidsPhosphatidylglycerols

Identifiers

PMID29607325

DOI10.1155/2018/6942452

PMCPMC5828411

OpenAlexW2787836748

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.